Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PGx-guided Post-Operative Opiate Prescriptions
NCT06669650Phase 4Active, not recruiting
- Sponsor
- University of Tennessee Graduate School of Medicine
- Start
- Sep 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of hydromorphone in postoperative pain, sponsored by University of Tennessee Graduate School of Medicine. Started Sep 2024; status: active, not recruiting.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06669650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06669650.